The effect of Vitamin D supplementation on serum cardiovascular biomarkers
Not Applicable
- Conditions
- Cardiovascular.Antihyperlipidaemic and antiarteriosclerotic drugs
- Registration Number
- IRCT2012091810868N1
- Lead Sponsor
- Golestan University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Postmenopausal women; absent of any serious diagnosed illnesses such as cardiovascular; diabetus mellitus; taking medications such as anti-diabetes; anti-hypertensive and anti-lipidemic agents; hormone replacement therapy (HRT); vitamin D and or calcium –D supplementation and smoking.
Exclusion criteria: using any medication which affect the outcome variables.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HDL. Timepoint: At baseline and after 12 weeks. Method of measurement: Serum.;Cholestrol. Timepoint: At baseline and after 12 weeks. Method of measurement: Serum.;LDL. Timepoint: At baseline and after 12 weeks. Method of measurement: Serum.;Triglyceride. Timepoint: At baseline and after 12 weeks. Method of measurement: serum.;FBS. Timepoint: At baseline and after 12 weeks. Method of measurement: Serum.;Blood Pressure. Timepoint: At baseline and after 12 weeks. Method of measurement: Serum.
- Secondary Outcome Measures
Name Time Method